Product Details for ANDA 040209
TRIFLUOPERAZINE HYDROCHLORIDE (TRIFLUOPERAZINE HYDROCHLORIDE)
EQ 1MG BASE
Marketing Status: Prescription
EQ 2MG BASE
Marketing Status: Prescription
EQ 5MG BASE
Marketing Status: Prescription
EQ 10MG BASE
Marketing Status: Prescription
EQ 1MG BASE
Marketing Status: Prescription
Active Ingredient: TRIFLUOPERAZINE HYDROCHLORIDE
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040209
Product Number: 001
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
TRIFLUOPERAZINE HYDROCHLORIDE (TRIFLUOPERAZINE HYDROCHLORIDE)
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040209
Product Number: 001
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 2MG BASE
Marketing Status: Prescription
Active Ingredient: TRIFLUOPERAZINE HYDROCHLORIDE
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040209
Product Number: 002
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
TRIFLUOPERAZINE HYDROCHLORIDE (TRIFLUOPERAZINE HYDROCHLORIDE)
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040209
Product Number: 002
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: TRIFLUOPERAZINE HYDROCHLORIDE
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040209
Product Number: 003
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
TRIFLUOPERAZINE HYDROCHLORIDE (TRIFLUOPERAZINE HYDROCHLORIDE)
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040209
Product Number: 003
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: TRIFLUOPERAZINE HYDROCHLORIDE
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A040209
Product Number: 004
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: TRIFLUOPERAZINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A040209
Product Number: 004
Approval Date: Jul 7, 1997
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information